The pharmaceutical industry is focused on the rollout of the Drug Quality and Security Act (DQSA) and improving the “safety of the supply chain”. Unfortunately, the problems surrounding opioid abuse happen in or after pharmacy.
Throughout the world, there is legislation either in place or coming down the pike to ensure a strong internal risk framework in the pharmaceutical and medical packaging industry.
The latest Global Packaging Trends Report from PMMI identified increasing awareness of health and wellness as one of the key trends driving development and innovation in packaging.
The U.S. incurs an estimated loss of $300 billion due to poor medication adherence every year. Thankfully in the last 8 – 10 years CMS (the Centers for Medicare and Medicaid Services) has been working to resolve this problem.